These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20426759)

  • 1. Mild improvement in mitochondrial function after a 3-year antiretroviral treatment interruption despite persistent impairment of mitochondrial DNA content.
    Negredo E; Romeu J; Rodríguez-Santiago B; Miró O; Garrabou G; Puig J; Pérez-Alvarez N; Moren C; Ruiz L; Bellido R; Miranda C; Clotet B
    Curr HIV Res; 2010 Jul; 8(5):379-85. PubMed ID: 20426759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Mitochondrial Function Among Healthy Infants Exposed to Antiretrovirals During Gestation, Delivery and the Neonatal Period.
    Noguera-Julian A; Morén C; Rovira N; Garrabou G; Catalán M; Sánchez E; Cardellach F; Miró Ó; Fortuny C
    Pediatr Infect Dis J; 2015 Dec; 34(12):1349-54. PubMed ID: 26372453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy.
    Casula M; Weverling GJ; Wit FW; Timmermans EC; Stek M; Lange JM; Reiss P
    J Infect Dis; 2005 Nov; 192(10):1794-800. PubMed ID: 16235179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short communication metabolic and mitochondrial effects of switching antiretroviral-experienced patients to enfuvirtide, tenofovir and saquinavir/ritonavir.
    Miró O; Garrabou G; López S; Deig E; Vidal I; Infante AB; Cardellach F; Casademont J; Pedrol E
    Antivir Ther; 2006; 11(5):625-30. PubMed ID: 16964831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART.
    Morén C; Noguera-Julian A; Rovira N; Garrabou G; Nicolàs M; Cardellach F; Martínez E; Sánchez E; Miró O; Fortuny C
    Antivir Ther; 2011; 16(5):719-24. PubMed ID: 21817193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study.
    Kim MJ; Leclercq P; Lanoy E; Cervera P; Antuna-Puente B; Maachi M; Dorofeev E; Slama L; Valantin MA; Costagliola D; Lombes A; Bastard JP; Capeau J
    Antivir Ther; 2007; 12(8):1273-83. PubMed ID: 18240867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.
    Saitoh A; Fenton T; Alvero C; Fletcher CV; Spector SA
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4236-42. PubMed ID: 17893156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of blood lymphocyte mitochondrial DNA for the monitoring of antiretroviral drug-induced mitochondrial DNA depletion.
    Petit C; Mathez D; Barthélémy C; Leste-Lasserre T; Naviaux RK; Sonigo P; Leibowitch J
    J Acquir Immune Defic Syndr; 2003 Aug; 33(4):461-9. PubMed ID: 12869834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.
    Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN
    Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study.
    Mussini C; Pinti M; Bugarini R; Borghi V; Nasi M; Nemes E; Troiano L; Guaraldi G; Bedini A; Sabin C; Esposito R; Cossarizza A
    AIDS; 2005 Oct; 19(15):1627-33. PubMed ID: 16184032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of mitochondrial DNA mutations in HIV-infected treatment-experienced individuals.
    Li M; Foli Y; Liu Z; Wang G; Hu Y; Lu Q; Selvaraj S; Lam W; Paintsil E
    HIV Med; 2017 Jan; 18(1):45-55. PubMed ID: 27328746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial effects of antiretroviral therapies in asymptomatic patients.
    López S; Miró O; Martínez E; Pedrol E; Rodríguez-Santiago B; Milinkovic A; Soler A; García-Viejo MA; Nunes V; Casademont J; Gatell JM; Cardellach F
    Antivir Ther; 2004 Feb; 9(1):47-55. PubMed ID: 15040536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control.
    Assoumou L; Weiss L; Piketty C; Burgard M; Melard A; Girard PM; Rouzioux C; Costagliola D;
    AIDS; 2015 Sep; 29(15):2003-7. PubMed ID: 26355572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of mitochondrial toxicity by analysis of mitochondrial protein expression in mononuclear cells.
    Lin CH; Sloan DD; Dang CH; Wagner T; Cabrera AJ; Tobin NH; Frenkel LM; Jerome KR
    Cytometry B Clin Cytom; 2009 May; 76(3):181-90. PubMed ID: 18823003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells.
    Sternfeld T; Schmid M; Tischleder A; Mudra S; Schlamp A; Kost BP; Gruber R; Youle M; Bogner JR; Goebel FD
    Antivir Ther; 2007; 12(5):769-78. PubMed ID: 17713160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
    Negredo E; Miró O; Rodríguez-Santiago B; Garrabou G; Estany C; Masabeu A; Force L; Barrufet P; Cucurull J; Domingo P; Alonso-Villaverde C; Bonjoch A; Morén C; Pérez-Alvarez N; Clotet B;
    Clin Infect Dis; 2009 Sep; 49(6):892-900. PubMed ID: 19663689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy.
    Miura T; Goto M; Hosoya N; Odawara T; Kitamura Y; Nakamura T; Iwamoto A
    J Med Virol; 2003 Aug; 70(4):497-505. PubMed ID: 12794710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of mitochondrial DNA content and enzyme levels in tenofovir DF-treated rats, rhesus monkeys and woodchucks.
    Biesecker G; Karimi S; Desjardins J; Meyer D; Abbott B; Bendele R; Richardson F
    Antiviral Res; 2003 May; 58(3):217-25. PubMed ID: 12767469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitofusin 2 mutations affect mitochondrial function by mitochondrial DNA depletion.
    Vielhaber S; Debska-Vielhaber G; Peeva V; Schoeler S; Kudin AP; Minin I; Schreiber S; Dengler R; Kollewe K; Zuschratter W; Kornblum C; Zsurka G; Kunz WS
    Acta Neuropathol; 2013 Feb; 125(2):245-56. PubMed ID: 22926664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of human mitochondrial DNA using a real-time PCR assay.
    Gourlain K; Amellal B; Ait Arkoub Z; Dupin N; Katlama C; Calvez V
    HIV Med; 2003 Jul; 4(3):287-92. PubMed ID: 12859329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.